NCT02805660 2021-04-06Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLCMirati Therapeutics Inc.Phase 1/2 Terminated83 enrolled 26 charts
NCT00323934 2015-01-08Study of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaMirati Therapeutics Inc.Phase 1 Completed42 enrolled